Correlation Between Abcellera Biologics and Patterson UTI

Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Patterson UTI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Patterson UTI into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abcellera Biologics and Patterson UTI Energy, you can compare the effects of market volatilities on Abcellera Biologics and Patterson UTI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Patterson UTI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Patterson UTI.

Diversification Opportunities for Abcellera Biologics and Patterson UTI

0.07

Correlation Coefficient

Abcellera Biologics  Patterson UTI

Significant diversification

The 3 months correlation between Abcellera and Patterson is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Patterson UTI Energy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Patterson UTI Energy and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Patterson UTI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Patterson UTI Energy has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Patterson UTI go up and down completely randomly.

Pair Corralation between Abcellera Biologics and Patterson UTI

Given the investment horizon of 90 days Abcellera Biologics is expected to under-perform the Patterson UTI. In addition to that, Abcellera Biologics is 1.21 times more volatile than Patterson UTI Energy. It trades about -0.05 of its total potential returns per unit of risk. Patterson UTI Energy is currently generating about -0.04 per unit of volatility. If you would invest  1,596  in Patterson UTI Energy on September 16, 2024 and sell it today you would lose (824.00) from holding Patterson UTI Energy or give up 51.63% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Abcellera Biologics  vs.  Patterson UTI Energy

Abcellera Biologics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Patterson UTI Energy

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Patterson UTI Energy has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Patterson UTI is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Abcellera Biologics and Patterson UTI

The main advantage of trading using opposite Abcellera Biologics and Patterson UTI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Patterson UTI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Patterson UTI will offset losses from the drop in Patterson UTI's long position.

The idea behind Abcellera Biologics and Patterson UTI Energy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.